Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells
HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apop...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 365; no. 2; pp. 386 - 392 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
11.01.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis. |
---|---|
AbstractList | HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis. HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anticancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG-CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) beta subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I beta expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis. HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be used as an anti-cancer therapy in addition to the designated applications. In the present study, we explored the possible synergistic pro-apoptotic effects and the underlying mechanisms when the two classes of inhibitors were combined. Exposure of HeLa cells to the combined treatment of mevastatin (an inhibitor of HMG CoA reductase) and trichostatin A (TSA) (an inhibitor of HDACs) synergistically induced apoptosis. Mevastatin treatment transcriptionally and translationally up-regulated RhoA expression in the cells by negative feedback mechanism. While TSA enhanced mevastatin-induced RhoA up-regulation, more importantly, it also accelerated mevastatin-mediated depletion of membrane-bound (geranylgeranylated) RhoA. Moreover, TSA treatment down-regulated protein geranylgeranyl transferase-I (GGTase-I) β subunit expression, which is one of the key enzymes for protein geranylgeranylation. Taken together, TSA down-regulated GGTase-I β expression, hence enhanced the statin-induced depletion of geranylgeranylated RhoA, which could be an important mechanism for the synergistic induction of the apoptosis. |
Author | Gan, Yehua Wang, Jian Wang, Xing Li Coselli, Joseph |
AuthorAffiliation | b Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St Luke’s Episcopal Hospital, Baylor College of Medicine, Houston, Texas 77030 a Laboratory of Molecular Biology, Peking University School and Hospital of Stomatology, Beijing 100081, China |
AuthorAffiliation_xml | – name: b Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St Luke’s Episcopal Hospital, Baylor College of Medicine, Houston, Texas 77030 – name: a Laboratory of Molecular Biology, Peking University School and Hospital of Stomatology, Beijing 100081, China |
Author_xml | – sequence: 1 givenname: Yehua surname: Gan fullname: Gan, Yehua email: kqyehuagan@bjmu.edu.cn organization: Laboratory of Molecular Biology and Center for TMJ Disorders, Peking University School and Hospital of Stomatology, 22 Zhongguancun Nandajie, Beijing 100081, PR China – sequence: 2 givenname: Jian surname: Wang fullname: Wang, Jian organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA – sequence: 3 givenname: Joseph surname: Coselli fullname: Coselli, Joseph organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA – sequence: 4 givenname: Xing Li surname: Wang fullname: Wang, Xing Li email: xlwang@bcm.tmc.edu organization: Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Texas Heart Institute at St. Luke’s Episcopal Hospital, MS NAB 2010, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17996726$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFq3DAQhkVJaTZJX6CHolNvdkeyLVtQCmFps4UtPbSF3IQkj7NavNJW8gb27SuzS5tcctJhvvk0M_8VufDBIyHvGJQMmPi4LY2JtuQAbclYCcBfkQUDCQVnUF-QBQCIgkt2f0muUtoCMFYL-YZcslZK0XKxIPHn0WN8cGlyljrfH-zkgqdhoHof9lNILlFzpKvvd8Uy3NKIM6ETZnbjjJtCpNr3dJMFeTjao7Y4HcdMpCeI83SFa00tjmO6Ia8HPSZ8e36vye-vX34tV8X6x9235e26sHVXT4XR0sraNNJ2Q1-LRnRNN1Ri6KTVYLkQUoDpGiE5VgPTDcPKVKwS1kBru05W1-Tzybs_mB32Fv0U9aj20e10PKqgnXpe8W6jHsKj4qxhHEQWfDgLYvhzwDSpnUvzCtpjOCTFoe6g5ZBBfgJtDClFHP59wkDNUamtmqNSc1SKMZWjyk3vn473v-WcTQY-nQDMR3p0GFWyDr3F3kW0k-qDe8n_Fw6eqUI |
CitedBy_id | crossref_primary_10_1016_j_ejmech_2017_05_016 crossref_primary_10_1016_j_bbrc_2008_07_012 crossref_primary_10_1080_13543776_2016_1216977 crossref_primary_10_1124_jpet_117_242081 crossref_primary_10_1016_j_procbio_2013_06_002 crossref_primary_10_1021_jm400179b crossref_primary_10_1002_jcb_24491 crossref_primary_10_1016_j_oraloncology_2009_05_563 crossref_primary_10_1016_j_gendis_2023_06_030 crossref_primary_10_1371_journal_pone_0029144 crossref_primary_10_1016_j_bbalip_2013_06_005 crossref_primary_10_1093_jmcb_mjaa066 crossref_primary_10_3390_ijms18051010 crossref_primary_10_3389_fonc_2022_790537 crossref_primary_10_1016_j_ejmech_2020_112844 |
Cites_doi | 10.1016/S0304-3835(01)00412-8 10.1016/S0021-9150(01)00613-X 10.1023/B:BREA.0000018423.47497.c6 10.1038/nrc1612 10.1093/carcin/bgi036 10.1016/S0168-8278(01)00257-4 10.1016/S0898-6568(02)00124-9 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X 10.1016/j.bbrc.2005.11.151 10.1097/00001622-200111000-00010 10.1158/0008-5472.CAN-04-2440 10.1158/0008-5472.CAN-03-2631 10.1042/BST0330891 10.1074/jbc.M412960200 10.1677/erc.1.01012 10.1161/01.RES.0000037983.07158.B1 10.1016/S0006-291X(03)00323-1 10.1016/S0021-9258(18)41945-X 10.1161/01.CIR.102.25.3104 10.1074/jbc.M213093200 10.1161/01.CIR.97.12.1129 10.1182/blood-2002-08-2675 10.1016/j.cardiores.2003.11.032 10.1164/ajrccm.157.5.9709020 10.1074/jbc.M201253200 10.18388/abp.1994_4718 10.1006/bcmd.2000.0376 10.1002/mc.10145 10.1128/MCB.25.5.1608-1619.2005 10.1016/S0021-9258(19)69848-0 10.1016/S0955-0674(03)00098-X 10.1210/en.2003-0098 10.1097/00062752-200207000-00010 10.1517/13543784.13.1.21 10.1016/j.canlet.2003.08.035 10.1006/bbrc.1994.2861 10.1038/sj.onc.1202792 10.1182/blood-2005-06-2409 |
ContentType | Journal Article |
Copyright | 2007 Elsevier Inc. |
Copyright_xml | – notice: 2007 Elsevier Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TM 5PM |
DOI | 10.1016/j.bbrc.2007.11.002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Nucleic Acids Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Nucleic Acids Abstracts |
DatabaseTitleList | MEDLINE Nucleic Acids Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1090-2104 |
EndPage | 392 |
ExternalDocumentID | 10_1016_j_bbrc_2007_11_002 17996726 S0006291X07023844 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL066053 – fundername: NHLBI NIH HHS grantid: R01 HL066053-04 – fundername: NHLBI NIH HHS grantid: R01-HL066053 |
GroupedDBID | --- --K --M -~X .55 .GJ .HR .~1 0R~ 1B1 1CY 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM 9M8 AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO AAYJJ ABEFU ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACKIV ACNCT ACRLP ADBBV ADEZE ADFGL ADIYS ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG COF CS3 D0L DM4 DOVZS EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q G8K GBLVA HLW HVGLF HZ~ IHE J1W K-O KOM L7B LG5 LX2 M41 MO0 MVM N9A O-L O9- OAUVE OHT OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K TWZ UQL WH7 WUQ X7M XPP XSW Y6R ZA5 ZGI ZKB ZMT ~02 ~G- ~KM AAHBH AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 7TM 5PM |
ID | FETCH-LOGICAL-c484t-ba9c94b59c8fd4656858f36f89ca0c266960b85692e3f1a51e3b3136cb07c8893 |
IEDL.DBID | AIKHN |
ISSN | 0006-291X |
IngestDate | Tue Sep 17 21:26:48 EDT 2024 Sun Sep 29 07:39:47 EDT 2024 Thu Sep 26 17:11:54 EDT 2024 Sat Sep 28 07:52:06 EDT 2024 Fri Feb 23 02:27:24 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | HMG-CoA TSA Statin RhoA Apoptosis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c484t-ba9c94b59c8fd4656858f36f89ca0c266960b85692e3f1a51e3b3136cb07c8893 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc2151206?pdf=render |
PMID | 17996726 |
PQID | 20480720 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2151206 proquest_miscellaneous_20480720 crossref_primary_10_1016_j_bbrc_2007_11_002 pubmed_primary_17996726 elsevier_sciencedirect_doi_10_1016_j_bbrc_2007_11_002 |
PublicationCentury | 2000 |
PublicationDate | 2008-01-11 |
PublicationDateYYYYMMDD | 2008-01-11 |
PublicationDate_xml | – month: 01 year: 2008 text: 2008-01-11 day: 11 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biochemical and biophysical research communications |
PublicationTitleAlternate | Biochem Biophys Res Commun |
PublicationYear | 2008 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Ghosh, Ghosh-Choudhury, Moyer, Mott, Thomas, Foster, Greenberg, Kreisberg (bib5) 1999; 18 Gan, Shen, Utama, Wang, Coselli, Wang (bib26) 2006; 340 Winter-Vann, Casey (bib1) 2005; 5 Li, Liu, Tupper, Bannerman, Winn, Sebti, Hamilton, Harlan (bib7) 2002; 277 Duan, Heckman, Boxer (bib18) 2005; 25 Zhong, Liang, Wang, Chang, Lee (bib33) 2005; 12 Laufs, La Fata, Plutzky, Liao (bib37) 1998; 97 Aznar, Lacal (bib30) 2001; 165 Rubins, Greatens, Kratzke, Tan, Polunovsky, Bitterman (bib6) 1998; 157 Cafforio, Dammacco, Gernone, Silvestris (bib11) 2005; 26 Donadelli, Costanzo, Faggioli, Scupoli, Moore, Bassi, Scarpa, Palmieri (bib17) 2003; 38 Denoyelle, Albanese, Uzan, Hong, Vannier, Soria, Soria (bib9) 2003; 15 Fritz (bib2) 2005; 27 Schmidt, Gust, Jung (bib14) 1999; 332 Sagami, Morita, Korenaga, Ogura (bib3) 1994; 41 Nimmanapalli, Fuino, Stobaugh, Richon, Bhalla (bib21) 2003; 101 Maggio, Rosato, Kramer, Dai, Rahmani, Paik, Czarnik, Payne, Spiegel, Grant (bib22) 2004; 64 Henderson, Mizzau, Paroni, Maestro, Schneider, Brancolini (bib27) 2003; 278 Aznar, Fernandez-Valeron, Espina, Lacal (bib13) 2004; 206 Rosato, Grant (bib36) 2004; 13 Gan, Shen, Wang, Wang, Utama, Wang, Wang (bib28) 2005; 280 Butler, Agus, Scher, Higgins, Rose, Cordon-Cardo, Thaler, Rifkind, Marks, Richon (bib15) 2000; 60 Moomaw, Casey (bib34) 1992; 267 Jones, Couldwell, Hinton, Su, He, Anker, Law (bib4) 1994; 205 Rahmani, Reese, Dai, Bauer, Payne, Dent, Spiegel, Grant (bib23) 2005; 65 Marks, Richon, Breslow, Rifkind (bib19) 2001; 13 Malliri, Collard (bib39) 2003; 15 Hall (bib31) 2005; 33 Porter, Turner, O’Regan, Balmforth, Ball (bib32) 2004; 61 Zhong, Wang, Chang, Lee (bib10) 2003; 144 Rossig, Li, Fisslthaler, Urbich, Fleming, Forstermann, Zeiher, Dimmeler (bib25) 2002; 91 Bordier (bib29) 1981; 256 Ridley (bib40) 2004; 84 Roskoski (bib12) 2003; 303 Melnick, Licht (bib20) 2002; 9 Richon, Zhou, Rifkind, Marks (bib35) 2001; 27 Herold, Ganslmayer, Ocker, Hermann, Geerts, Hahn, Schuppan (bib16) 2002; 36 Laufs, Endres, Custodis, Gertz, Nickenig, Liao, Bohm (bib38) 2000; 102 Blanco-Colio, Villa, Ortego, Hernandez-Presa, Pascual, Plaza, Egido (bib8) 2002; 161 Gao, Rahmani, Shi, Dent, Grant (bib24) 2006; 107 11248412 - Cancer Lett. 2001 Apr 10;165(1):1-10 9603146 - Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1616-22 11120702 - Circulation. 2000 Dec 19;102(25):3104-10 12556448 - J Biol Chem. 2003 Apr 4;278(14):12579-89 15059916 - Cancer Res. 2004 Apr 1;64(7):2590-600 7811252 - Biochem Biophys Res Commun. 1994 Dec 30;205(3):1681-7 15864282 - Nat Rev Cancer. 2005 May;5(5):405-12 12042707 - Curr Opin Hematol. 2002 Jul;9(4):322-32 14999150 - Breast Cancer Res Treat. 2004 Mar;84(1):13-9 11882313 - Atherosclerosis. 2002 Mar;161(1):17-26 1512274 - J Biol Chem. 1992 Aug 25;267(24):17438-43 11830335 - J Hepatol. 2002 Feb;36(2):233-40 16172195 - Endocr Relat Cancer. 2005 Sep;12(3):615-29 10575368 - Arch Pharm (Weinheim). 1999 Oct;332(10):353-7 11358386 - Blood Cells Mol Dis. 2001 Jan-Feb;27(1):260-4 12446442 - Blood. 2003 Apr 15;101(8):3236-9 11016644 - Cancer Res. 2000 Sep 15;60(18):5165-70 15013523 - Cancer Lett. 2004 Apr 8;206(2):181-91 16338217 - Biochem Biophys Res Commun. 2006 Feb 3;340(1):29-34 16246005 - Biochem Soc Trans. 2005 Nov;33(Pt 5):891-5 12646157 - Biochem Biophys Res Commun. 2003 Mar 28;303(1):1-7 9537338 - Circulation. 1998 Mar 31;97(12):1129-35 14502645 - Mol Carcinog. 2003 Oct;38(2):59-69 6257680 - J Biol Chem. 1981 Feb 25;256(4):1604-7 12933658 - Endocrinology. 2003 Sep;144(9):3852-9 15713621 - Mol Cell Biol. 2005 Mar;25(5):1608-19 10435593 - Oncogene. 1999 Jul 15;18(28):4120-30 11673688 - Curr Opin Oncol. 2001 Nov;13(6):477-83 12411399 - Circ Res. 2002 Nov 1;91(9):837-44 15705602 - Carcinogenesis. 2005 May;26(5):883-91 14680450 - Expert Opin Investig Drugs. 2004 Jan;13(1):21-38 14985071 - Cardiovasc Res. 2004 Mar 1;61(4):745-55 15781658 - Cancer Res. 2005 Mar 15;65(6):2422-32 16211237 - Int J Oncol. 2005 Nov;27(5):1401-9 12531431 - Cell Signal. 2003 Mar;15(3):327-38 16141349 - Blood. 2006 Jan 1;107(1):241-9 11839765 - J Biol Chem. 2002 May 3;277(18):15309-16 15722551 - J Biol Chem. 2005 Apr 22;280(16):16467-75 14519393 - Curr Opin Cell Biol. 2003 Oct;15(5):583-9 7856400 - Acta Biochim Pol. 1994;41(3):293-302 Gao (10.1016/j.bbrc.2007.11.002_bib24) 2006; 107 Aznar (10.1016/j.bbrc.2007.11.002_bib13) 2004; 206 Herold (10.1016/j.bbrc.2007.11.002_bib16) 2002; 36 Maggio (10.1016/j.bbrc.2007.11.002_bib22) 2004; 64 Ghosh (10.1016/j.bbrc.2007.11.002_bib5) 1999; 18 Malliri (10.1016/j.bbrc.2007.11.002_bib39) 2003; 15 Fritz (10.1016/j.bbrc.2007.11.002_bib2) 2005; 27 Porter (10.1016/j.bbrc.2007.11.002_bib32) 2004; 61 Rosato (10.1016/j.bbrc.2007.11.002_bib36) 2004; 13 Winter-Vann (10.1016/j.bbrc.2007.11.002_bib1) 2005; 5 Schmidt (10.1016/j.bbrc.2007.11.002_bib14) 1999; 332 Richon (10.1016/j.bbrc.2007.11.002_bib35) 2001; 27 Blanco-Colio (10.1016/j.bbrc.2007.11.002_bib8) 2002; 161 Rahmani (10.1016/j.bbrc.2007.11.002_bib23) 2005; 65 Denoyelle (10.1016/j.bbrc.2007.11.002_bib9) 2003; 15 Rubins (10.1016/j.bbrc.2007.11.002_bib6) 1998; 157 Gan (10.1016/j.bbrc.2007.11.002_bib28) 2005; 280 Donadelli (10.1016/j.bbrc.2007.11.002_bib17) 2003; 38 Gan (10.1016/j.bbrc.2007.11.002_bib26) 2006; 340 Laufs (10.1016/j.bbrc.2007.11.002_bib37) 1998; 97 Marks (10.1016/j.bbrc.2007.11.002_bib19) 2001; 13 Duan (10.1016/j.bbrc.2007.11.002_bib18) 2005; 25 Bordier (10.1016/j.bbrc.2007.11.002_bib29) 1981; 256 Rossig (10.1016/j.bbrc.2007.11.002_bib25) 2002; 91 Ridley (10.1016/j.bbrc.2007.11.002_bib40) 2004; 84 Sagami (10.1016/j.bbrc.2007.11.002_bib3) 1994; 41 Roskoski (10.1016/j.bbrc.2007.11.002_bib12) 2003; 303 Aznar (10.1016/j.bbrc.2007.11.002_bib30) 2001; 165 Nimmanapalli (10.1016/j.bbrc.2007.11.002_bib21) 2003; 101 Hall (10.1016/j.bbrc.2007.11.002_bib31) 2005; 33 Melnick (10.1016/j.bbrc.2007.11.002_bib20) 2002; 9 Zhong (10.1016/j.bbrc.2007.11.002_bib10) 2003; 144 Moomaw (10.1016/j.bbrc.2007.11.002_bib34) 1992; 267 Laufs (10.1016/j.bbrc.2007.11.002_bib38) 2000; 102 Jones (10.1016/j.bbrc.2007.11.002_bib4) 1994; 205 Henderson (10.1016/j.bbrc.2007.11.002_bib27) 2003; 278 Zhong (10.1016/j.bbrc.2007.11.002_bib33) 2005; 12 Cafforio (10.1016/j.bbrc.2007.11.002_bib11) 2005; 26 Butler (10.1016/j.bbrc.2007.11.002_bib15) 2000; 60 Li (10.1016/j.bbrc.2007.11.002_bib7) 2002; 277 |
References_xml | – volume: 107 start-page: 241 year: 2006 end-page: 249 ident: bib24 article-title: Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress publication-title: Blood contributor: fullname: Grant – volume: 340 start-page: 29 year: 2006 end-page: 34 ident: bib26 article-title: Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Wang – volume: 277 start-page: 15309 year: 2002 end-page: 15316 ident: bib7 article-title: Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells publication-title: J. Biol. Chem. contributor: fullname: Harlan – volume: 97 start-page: 1129 year: 1998 end-page: 1135 ident: bib37 article-title: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors publication-title: Circulation contributor: fullname: Liao – volume: 13 start-page: 21 year: 2004 end-page: 38 ident: bib36 article-title: Histone deacetylase inhibitors in clinical development publication-title: Expert Opin. Investig. Drugs contributor: fullname: Grant – volume: 205 start-page: 1681 year: 1994 end-page: 1687 ident: bib4 article-title: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Law – volume: 12 start-page: 615 year: 2005 end-page: 629 ident: bib33 article-title: Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling publication-title: Endocr. Relat. Cancer contributor: fullname: Lee – volume: 102 start-page: 3104 year: 2000 end-page: 3110 ident: bib38 article-title: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription publication-title: Circulation contributor: fullname: Bohm – volume: 9 start-page: 322 year: 2002 end-page: 332 ident: bib20 article-title: Histone deacetylases as therapeutic targets in hematologic malignancies publication-title: Curr. Opin. Hematol. contributor: fullname: Licht – volume: 13 start-page: 477 year: 2001 end-page: 483 ident: bib19 article-title: Histone deacetylase inhibitors as new cancer drugs publication-title: Curr. Opin. Oncol. contributor: fullname: Rifkind – volume: 84 start-page: 13 year: 2004 end-page: 19 ident: bib40 article-title: Rho proteins and cancer publication-title: Breast Cancer Res. Treat. contributor: fullname: Ridley – volume: 41 start-page: 293 year: 1994 end-page: 302 ident: bib3 article-title: Purification of geranylgeranyl diphosphate synthase from bovine brain publication-title: Acta Biochim. Pol. contributor: fullname: Ogura – volume: 256 start-page: 1604 year: 1981 end-page: 1607 ident: bib29 article-title: Phase separation of integral membrane proteins in Triton X-114 solution publication-title: J. Biol. Chem. contributor: fullname: Bordier – volume: 27 start-page: 260 year: 2001 end-page: 264 ident: bib35 article-title: Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers publication-title: Blood Cells Mol. Dis. contributor: fullname: Marks – volume: 25 start-page: 1608 year: 2005 end-page: 1619 ident: bib18 article-title: Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas publication-title: Mol. Cell. Biol. contributor: fullname: Boxer – volume: 267 start-page: 17438 year: 1992 end-page: 17443 ident: bib34 article-title: Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements publication-title: J. Biol. Chem. contributor: fullname: Casey – volume: 64 start-page: 2590 year: 2004 end-page: 2600 ident: bib22 article-title: The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells publication-title: Cancer Res. contributor: fullname: Grant – volume: 5 start-page: 405 year: 2005 end-page: 412 ident: bib1 article-title: Post-prenylation-processing enzymes as new targets in oncogenesis publication-title: Nat. Rev. Cancer contributor: fullname: Casey – volume: 157 start-page: 1616 year: 1998 end-page: 1622 ident: bib6 article-title: Lovastatin induces apoptosis in malignant mesothelioma cells publication-title: Am. J. Respir. Crit. Care Med. contributor: fullname: Bitterman – volume: 60 start-page: 5165 year: 2000 end-page: 5170 ident: bib15 article-title: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo publication-title: Cancer Res. contributor: fullname: Richon – volume: 165 start-page: 1 year: 2001 end-page: 10 ident: bib30 article-title: Rho signals to cell growth and apoptosis publication-title: Cancer Lett. contributor: fullname: Lacal – volume: 38 start-page: 59 year: 2003 end-page: 69 ident: bib17 article-title: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells publication-title: Mol. Carcinog. contributor: fullname: Palmieri – volume: 161 start-page: 17 year: 2002 end-page: 26 ident: bib8 article-title: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation publication-title: Atherosclerosis contributor: fullname: Egido – volume: 15 start-page: 327 year: 2003 end-page: 338 ident: bib9 article-title: Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells publication-title: Cell Signal contributor: fullname: Soria – volume: 36 start-page: 233 year: 2002 end-page: 240 ident: bib16 article-title: The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells publication-title: J. Hepatol. contributor: fullname: Schuppan – volume: 144 start-page: 3852 year: 2003 end-page: 3859 ident: bib10 article-title: Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis publication-title: Endocrinology contributor: fullname: Lee – volume: 26 start-page: 883 year: 2005 end-page: 891 ident: bib11 article-title: Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells publication-title: Carcinogenesis contributor: fullname: Silvestris – volume: 15 start-page: 583 year: 2003 end-page: 589 ident: bib39 article-title: Role of Rho-family proteins in cell adhesion and cancer publication-title: Curr. Opin. Cell Biol. contributor: fullname: Collard – volume: 332 start-page: 353 year: 1999 end-page: 357 ident: bib14 article-title: Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells publication-title: Arch. Pharm. (Weinheim) contributor: fullname: Jung – volume: 303 start-page: 1 year: 2003 end-page: 7 ident: bib12 article-title: Protein prenylation: a pivotal posttranslational process publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Roskoski – volume: 278 start-page: 12579 year: 2003 end-page: 12589 ident: bib27 article-title: Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) publication-title: J. Biol. Chem. contributor: fullname: Brancolini – volume: 27 start-page: 1401 year: 2005 end-page: 1409 ident: bib2 article-title: HMG-CoA reductase inhibitors (statins) as anticancer drugs (review) publication-title: Int. J. Oncol. contributor: fullname: Fritz – volume: 33 start-page: 891 year: 2005 end-page: 895 ident: bib31 article-title: Rho GTPases and the control of cell behaviour publication-title: Biochem. Soc. Trans. contributor: fullname: Hall – volume: 280 start-page: 16467 year: 2005 end-page: 16475 ident: bib28 article-title: Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase publication-title: J. Biol. Chem. contributor: fullname: Wang – volume: 18 start-page: 4120 year: 1999 end-page: 4130 ident: bib5 article-title: Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line publication-title: Oncogene contributor: fullname: Kreisberg – volume: 101 start-page: 3236 year: 2003 end-page: 3239 ident: bib21 article-title: Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells publication-title: Blood contributor: fullname: Bhalla – volume: 65 start-page: 2422 year: 2005 end-page: 2432 ident: bib23 article-title: Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species publication-title: Cancer Res. contributor: fullname: Grant – volume: 91 start-page: 837 year: 2002 end-page: 844 ident: bib25 article-title: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis publication-title: Circ. Res. contributor: fullname: Dimmeler – volume: 61 start-page: 745 year: 2004 end-page: 755 ident: bib32 article-title: Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA publication-title: Cardiovasc. Res. contributor: fullname: Ball – volume: 206 start-page: 181 year: 2004 end-page: 191 ident: bib13 article-title: Rho GTPases: potential candidates for anticancer therapy publication-title: Cancer Lett. contributor: fullname: Lacal – volume: 165 start-page: 1 year: 2001 ident: 10.1016/j.bbrc.2007.11.002_bib30 article-title: Rho signals to cell growth and apoptosis publication-title: Cancer Lett. doi: 10.1016/S0304-3835(01)00412-8 contributor: fullname: Aznar – volume: 161 start-page: 17 year: 2002 ident: 10.1016/j.bbrc.2007.11.002_bib8 article-title: 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00613-X contributor: fullname: Blanco-Colio – volume: 84 start-page: 13 year: 2004 ident: 10.1016/j.bbrc.2007.11.002_bib40 article-title: Rho proteins and cancer publication-title: Breast Cancer Res. Treat. doi: 10.1023/B:BREA.0000018423.47497.c6 contributor: fullname: Ridley – volume: 5 start-page: 405 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib1 article-title: Post-prenylation-processing enzymes as new targets in oncogenesis publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1612 contributor: fullname: Winter-Vann – volume: 26 start-page: 883 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib11 article-title: Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgi036 contributor: fullname: Cafforio – volume: 36 start-page: 233 year: 2002 ident: 10.1016/j.bbrc.2007.11.002_bib16 article-title: The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells publication-title: J. Hepatol. doi: 10.1016/S0168-8278(01)00257-4 contributor: fullname: Herold – volume: 15 start-page: 327 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib9 article-title: Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells publication-title: Cell Signal doi: 10.1016/S0898-6568(02)00124-9 contributor: fullname: Denoyelle – volume: 332 start-page: 353 year: 1999 ident: 10.1016/j.bbrc.2007.11.002_bib14 article-title: Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells publication-title: Arch. Pharm. (Weinheim) doi: 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X contributor: fullname: Schmidt – volume: 340 start-page: 29 year: 2006 ident: 10.1016/j.bbrc.2007.11.002_bib26 article-title: Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2005.11.151 contributor: fullname: Gan – volume: 13 start-page: 477 year: 2001 ident: 10.1016/j.bbrc.2007.11.002_bib19 article-title: Histone deacetylase inhibitors as new cancer drugs publication-title: Curr. Opin. Oncol. doi: 10.1097/00001622-200111000-00010 contributor: fullname: Marks – volume: 65 start-page: 2422 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib23 article-title: Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2440 contributor: fullname: Rahmani – volume: 64 start-page: 2590 year: 2004 ident: 10.1016/j.bbrc.2007.11.002_bib22 article-title: The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-03-2631 contributor: fullname: Maggio – volume: 27 start-page: 1401 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib2 article-title: HMG-CoA reductase inhibitors (statins) as anticancer drugs (review) publication-title: Int. J. Oncol. contributor: fullname: Fritz – volume: 33 start-page: 891 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib31 article-title: Rho GTPases and the control of cell behaviour publication-title: Biochem. Soc. Trans. doi: 10.1042/BST0330891 contributor: fullname: Hall – volume: 280 start-page: 16467 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib28 article-title: Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase publication-title: J. Biol. Chem. doi: 10.1074/jbc.M412960200 contributor: fullname: Gan – volume: 60 start-page: 5165 year: 2000 ident: 10.1016/j.bbrc.2007.11.002_bib15 article-title: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo publication-title: Cancer Res. contributor: fullname: Butler – volume: 12 start-page: 615 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib33 article-title: Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling publication-title: Endocr. Relat. Cancer doi: 10.1677/erc.1.01012 contributor: fullname: Zhong – volume: 91 start-page: 837 year: 2002 ident: 10.1016/j.bbrc.2007.11.002_bib25 article-title: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis publication-title: Circ. Res. doi: 10.1161/01.RES.0000037983.07158.B1 contributor: fullname: Rossig – volume: 303 start-page: 1 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib12 article-title: Protein prenylation: a pivotal posttranslational process publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(03)00323-1 contributor: fullname: Roskoski – volume: 267 start-page: 17438 year: 1992 ident: 10.1016/j.bbrc.2007.11.002_bib34 article-title: Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)41945-X contributor: fullname: Moomaw – volume: 102 start-page: 3104 year: 2000 ident: 10.1016/j.bbrc.2007.11.002_bib38 article-title: Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription publication-title: Circulation doi: 10.1161/01.CIR.102.25.3104 contributor: fullname: Laufs – volume: 278 start-page: 12579 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib27 article-title: Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) publication-title: J. Biol. Chem. doi: 10.1074/jbc.M213093200 contributor: fullname: Henderson – volume: 97 start-page: 1129 year: 1998 ident: 10.1016/j.bbrc.2007.11.002_bib37 article-title: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors publication-title: Circulation doi: 10.1161/01.CIR.97.12.1129 contributor: fullname: Laufs – volume: 101 start-page: 3236 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib21 article-title: Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells publication-title: Blood doi: 10.1182/blood-2002-08-2675 contributor: fullname: Nimmanapalli – volume: 61 start-page: 745 year: 2004 ident: 10.1016/j.bbrc.2007.11.002_bib32 article-title: Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA publication-title: Cardiovasc. Res. doi: 10.1016/j.cardiores.2003.11.032 contributor: fullname: Porter – volume: 157 start-page: 1616 year: 1998 ident: 10.1016/j.bbrc.2007.11.002_bib6 article-title: Lovastatin induces apoptosis in malignant mesothelioma cells publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/ajrccm.157.5.9709020 contributor: fullname: Rubins – volume: 277 start-page: 15309 year: 2002 ident: 10.1016/j.bbrc.2007.11.002_bib7 article-title: Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M201253200 contributor: fullname: Li – volume: 41 start-page: 293 year: 1994 ident: 10.1016/j.bbrc.2007.11.002_bib3 article-title: Purification of geranylgeranyl diphosphate synthase from bovine brain publication-title: Acta Biochim. Pol. doi: 10.18388/abp.1994_4718 contributor: fullname: Sagami – volume: 27 start-page: 260 year: 2001 ident: 10.1016/j.bbrc.2007.11.002_bib35 article-title: Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers publication-title: Blood Cells Mol. Dis. doi: 10.1006/bcmd.2000.0376 contributor: fullname: Richon – volume: 38 start-page: 59 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib17 article-title: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells publication-title: Mol. Carcinog. doi: 10.1002/mc.10145 contributor: fullname: Donadelli – volume: 25 start-page: 1608 year: 2005 ident: 10.1016/j.bbrc.2007.11.002_bib18 article-title: Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.25.5.1608-1619.2005 contributor: fullname: Duan – volume: 256 start-page: 1604 year: 1981 ident: 10.1016/j.bbrc.2007.11.002_bib29 article-title: Phase separation of integral membrane proteins in Triton X-114 solution publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)69848-0 contributor: fullname: Bordier – volume: 15 start-page: 583 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib39 article-title: Role of Rho-family proteins in cell adhesion and cancer publication-title: Curr. Opin. Cell Biol. doi: 10.1016/S0955-0674(03)00098-X contributor: fullname: Malliri – volume: 144 start-page: 3852 year: 2003 ident: 10.1016/j.bbrc.2007.11.002_bib10 article-title: Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis publication-title: Endocrinology doi: 10.1210/en.2003-0098 contributor: fullname: Zhong – volume: 9 start-page: 322 year: 2002 ident: 10.1016/j.bbrc.2007.11.002_bib20 article-title: Histone deacetylases as therapeutic targets in hematologic malignancies publication-title: Curr. Opin. Hematol. doi: 10.1097/00062752-200207000-00010 contributor: fullname: Melnick – volume: 13 start-page: 21 year: 2004 ident: 10.1016/j.bbrc.2007.11.002_bib36 article-title: Histone deacetylase inhibitors in clinical development publication-title: Expert Opin. Investig. Drugs doi: 10.1517/13543784.13.1.21 contributor: fullname: Rosato – volume: 206 start-page: 181 year: 2004 ident: 10.1016/j.bbrc.2007.11.002_bib13 article-title: Rho GTPases: potential candidates for anticancer therapy publication-title: Cancer Lett. doi: 10.1016/j.canlet.2003.08.035 contributor: fullname: Aznar – volume: 205 start-page: 1681 year: 1994 ident: 10.1016/j.bbrc.2007.11.002_bib4 article-title: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1994.2861 contributor: fullname: Jones – volume: 18 start-page: 4120 year: 1999 ident: 10.1016/j.bbrc.2007.11.002_bib5 article-title: Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line publication-title: Oncogene doi: 10.1038/sj.onc.1202792 contributor: fullname: Ghosh – volume: 107 start-page: 241 year: 2006 ident: 10.1016/j.bbrc.2007.11.002_bib24 article-title: Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stress publication-title: Blood doi: 10.1182/blood-2005-06-2409 contributor: fullname: Gao |
SSID | ssj0011469 |
Score | 2.0165298 |
Snippet | HMG-CoA reductase inhibitors and histone deacetylases (HDACs) inhibitors have been shown to induce apoptosis in a variety of cells, which could potentially be... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 386 |
SubjectTerms | Acyl Coenzyme A - metabolism Apoptosis Apoptosis - drug effects Dose-Response Relationship, Drug HeLa Cells Histone Deacetylase Inhibitors Histone Deacetylases - metabolism HMG-CoA Humans Hydroxamic Acids - administration & dosage Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage Lovastatin - administration & dosage Lovastatin - analogs & derivatives RhoA Statin TSA |
Title | Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells |
URI | https://dx.doi.org/10.1016/j.bbrc.2007.11.002 https://www.ncbi.nlm.nih.gov/pubmed/17996726 https://search.proquest.com/docview/20480720 https://pubmed.ncbi.nlm.nih.gov/PMC2151206 |
Volume | 365 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61WyG4IGiBLtDiA-KCTPOyYx-XFSU82gtU2ltkO44apCarJD3shd_OOHFKFyoO3KLElib-rHl4Zj4DvC4DExUY-1ApSk2TggdUJoHLwZcJN7hJSusanM_OeXaRfF6x1Q4sp14YV1bpdf-o0wdt7d-c-NU8WVeV6_ENeCTDFW5atDtJsgt7Q5JoBnuLT1-y85tkAioD7wVz6ib43pmxzEvr1jMZOjJPf7pyh3362__8s4zyll06fQQPvUNJFqPMj2HH1vtwsKgxmL7akDdkKPEczs734d776en-crro7QDabxvXADgwNhMM0Uc-WdKURK2bdd90VUf0hmRnH-myWZDWkb32aPxw7GWlUSO0RNUFGZiLa0sKVLK236BXbrtbQ6qaZParIi5T0D2Bi9MP35cZ9VcxUJOIpKdaSSMTzaQRZeEo1gQTZcxLIY1CtDnHQEgLxmVk4zJULLSxjsOYGx2kRqBP9BRmNcpwCMQwJW3MCsdViMAwoY01kURHTCkti2AObycA8vXIuJFPpWg_cgeXuzozxdAlR7jmwCaM8q19k6NJ-Oe8VxOgOS63-3dV2-a6y6Ohyz5COZ6N8P6WIsXgMI34HNIt4G8GOKru7S91dTlQdg-OVcCf_6e0L-DBWKcS0jB8CbO-vbZH6Az1-hh23_0Mj_2W_wW13gpa |
link.rule.ids | 230,315,783,787,888,4511,24130,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKESoXBC2U5VUfEBdkmoft2MdlRQmw2wuttLfIdhw1SCSrJD3shd_O2HFKFxAHblEykSb-RvOIZz4j9LqKTFJC7UOkqDShJY-IpJHbg68oN2AklXUDzqtznl_Sz2u23kOLaRbGtVUG3z_6dO-tw53TsJqnm7p2M74RT2S8BqOFuEPpHXSXOv4sMOp3P276PNzUbciBOXHiYXJmbPLSugs8ho7KM_xb-Ut0-jP7_L2J8lZUOnuIHoR0Es9HjR-hPdscoqN5A6X09y1-g32Dp_9zfojuvZ-uDhbTMW9HqPu6deN_nq8ZQ4E-ssnitsJq026Gtq97rLc4X30ki3aOO0f1OkDoA9mrWoM_6LBqSux5ixuLS3CxdthCTm77WyJ1g3O7VNjtE_SP0eXZh4tFTsJBDMRQQQeilTSSaiaNqEpHsCaYqFJeCWkUYM05lEFaMC4Tm1axYrFNdRqn3OgoMwIyoidovwEdniJsmJI2ZaVjKgRgmNDGmkRCGqaUlmU0Q28nAIrNyLdRTI1o3woHlzs4M4PCpQC4ZohNGBU7VlNAQPjneycToAUst_t21dj2ui8SP2OfgB7HI7y_tMigNMwSPkPZDvA3Ao6oe_dJU195wm6fVkX82X9qe4IO8ovVslh-Ov_yHN0fO1ZiEscv0P7QXduXkBYN-pU3-59A-Qs8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synergistic+induction+of+apoptosis+by+HMG-CoA+reductase+inhibitor+and+histone+deacetylases+inhibitor+in+HeLa+cells&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Gan%2C+Yehua&rft.au=Wang%2C+Jian&rft.au=Coselli%2C+Joseph&rft.au=Wang%2C+Xing+Li&rft.date=2008-01-11&rft.pub=Elsevier+Inc&rft.issn=0006-291X&rft.eissn=1090-2104&rft.volume=365&rft.issue=2&rft.spage=386&rft.epage=392&rft_id=info:doi/10.1016%2Fj.bbrc.2007.11.002&rft.externalDocID=S0006291X07023844 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon |